Talphera, Inc. Receives Nasdaq Non-Compliance Notice for Minimum Bid Price Requirement
Key Points:
- Talphera, Inc. (NASDAQ: TLPH) has received a formal notice of non-compliance from the Nasdaq Stock Market regarding its minimum bid price requirement.
- The company’s common stock has not maintained the minimum required closing bid price of \$1.00 per share for 30 consecutive business days, as mandated by Nasdaq Listing Rule 5550(a)(2).
- This notice does not immediately affect the listing or trading of Talphera’s common stock on the Nasdaq Capital Market.
- Talphera has 180 calendar days—until September 7, 2026—to regain compliance. To do so, the stock’s closing bid price must be at least \$1.00 per share for a minimum of 10 consecutive business days within this period.
- If compliance is not regained within 180 days, the company may be eligible for an additional 180-day compliance period if it meets all other Nasdaq listing standards (except for the minimum bid price), and notifies Nasdaq of its intention to cure the deficiency, potentially via a reverse stock split.
- If Nasdaq determines Talphera cannot cure the deficiency or is otherwise ineligible, the company will receive a delisting notice for its common stock.
Details Investors Need to Know
Shareholder Impact:
- Potential for Delisting: If Talphera fails to regain compliance, there is a risk its shares may be delisted from the Nasdaq Capital Market, which could significantly reduce liquidity and potentially depress share value.
- Reverse Stock Split Possible: To regain compliance, the company may consider a reverse stock split. While this can restore compliance, it also may have implications for shareholders, including a reduced number of outstanding shares and potential volatility in share price.
- Active Monitoring and Disclosure: Talphera states it intends to actively monitor the stock price and evaluate options to regain compliance. The company has disclosed this event via a Form 8-K filing, ensuring transparency with investors and compliance with Nasdaq Listing Rule 5810(b).
- No Immediate Impact on Listing: The company’s shares will continue to trade as usual on the Nasdaq Capital Market during the compliance period.
- Forward-Looking Statements: Management cautions that statements regarding regaining compliance and evaluating options are forward-looking and subject to risks and uncertainties, including those detailed in the company’s latest SEC filings.
Background Information
- Company: Talphera, Inc. (formerly AcelRx Pharmaceuticals Inc.)
- Trading Symbol: TLPH
- Exchange: Nasdaq Capital Market
- Industry: Pharmaceutical Preparations
- Business Address: 1850 Gateway Drive, Suite 175, San Mateo, CA 94404
- Contact: (650) 216-3500
- Filing Date: March 13, 2026
- Earliest Event Reported: March 11, 2026
- Signed by: Raffi Asadorian, Chief Financial Officer
Potential Price-Sensitive Elements:
- The risk of delisting and possible reverse stock split are both events that can substantially affect Talphera’s share price and investor confidence.
- Continued non-compliance could result in reduced access to capital markets and diminished liquidity for shareholders.
- Any announcement regarding a reverse split or further compliance actions should be closely monitored by investors.
Disclaimer:
This article is for informational purposes only and does not constitute investment advice. Investors should carefully review all company filings and consult with their financial advisors before making any investment decisions. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated. The information provided herein is based on public filings as of the date indicated and may not reflect subsequent developments.
View TALPHERA, INC. Historical chart here
